Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar



Rating:

Share or cite this content

Citations should be made in the following way:
V. Cottin (Lyon, France). Pulmonary fibrosis: ongoing trials and future treatment. Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar

Member's Comments

No comment yet.

Related content which might interest you: A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials Source: Eur Respir J 2015; 46: 243-249 Year: 2015 Idiopathic pulmonary fibrosis: from clinical trials to real-life experiences Source: Eur Respir Rev 2015; 24: 420-427 Year: 2015 Pulmonary rehabilitation in lymphangioleiomyomatosis: a controlled clinical trial Source: Eur Respir J 2016; 47:1452-1460 Year: 2016 Preliminary results of pulmonary rehabilitation in interstitial lung diseases: A randomised controlled trial B32220095560 Source: Annual Congress 2011 - Exercise training: new populations, new techniques Year: 2011 Generalisability of recent clinical trials in idiopathic pulmonary fibrosis to everyday clinical practice Source: International Congress 2015 – Treatment of IPF Year: 2015 Challenges in IPF trials: the point on endpoints Source: Annual Congress 2010 - Idiopathic pulmonary fibrosis: present understandings and future directions Year: 2010 How to treat IPF: lessons from the NIH-IPF-Net treatment trials Source: International Congress 2014 – Ceremony for the ERS Idiopathic Pulmonary Fibrosis Research Award 2014 - Hot Topic: "Understanding and treating idiopathic pulmonary fibrosis (IPF) in the 21st century" Year: 2014 Idiopathic pulmonary fibrosis trials: recommendations for the jury Source: Eur Respir J 2011; 38: 1002-1004 Year: 2011 Recent clinical trials in idiopathic pulmonary fibrosis and the BUILD-1 study Source: Eur Respir Rev 2008; 17: 116-122 Year: 2008 The concept of cystic fibrosis pulmonary exacerbation in clinical medicine and as a trial end-point Source: Annual Congress 2008 - Exacerbations of chronic respiratory disease – state of the art Year: 2008 Clinical trials in idiopathic pulmonary fibrosis: a framework for moving forward Source: Eur Respir J 2013; 42: 1446-1448 Year: 2013 End-points and clinical trial design in pulmonary arterial hypertension: have we made progress? Source: Eur Respir J 2009; 34: 231-242 Year: 2009 Idiopathic pulmonary fibrosis: lessons from clinical trials over the past 25 years Source: Eur Respir J, 50 (4) 1701209; 10.1183/13993003.01209-2017 Year: 2017 Challenges in setting up Phase III idiopathic pulmonary fibrosis studies during the COVID-19 pandemic: Experience from the STARSCAPE program Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia Year: 2021 Benefit of continued pirfenidone treatment following hospitalisation within the first 6 months of therapy—Ad hoc analysis from three phase 3 trials in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases Year: 2015 Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial Source: Eur Respir J 2013; 42: 1622-1632 Year: 2013 Phase 2 clinical trial of PBI-4050 in patients with idiopathic pulmonary fibrosis Source: Eur Respir J, 53 (3) 1800663; 10.1183/13993003.00663-2018 Year: 2019 The effects of pulmonary rehabilitation in patients with non-cystic fibrosis bronchiectasis- A randomised controlled trial Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation and chronic care Year: 2017 Maintaining benefits following pulmonary rehabilitation: a randomised controlled trial Source: Eur Respir J 2010; 35: 571-577 Year: 2010